Evidence map›Paper›PMID 35671088›Full record

ArticleNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association2022

Availability of assisted peritoneal dialysis in Europe: call for increased and equal access.

Edwina A Brown, Agneta Ekstrand, Maurizio Gallieni, Maite Rivera Gorrín, Helga Gudmundsdottir, Anabela Malho Guedes, Marco Heidempergher, Benno Kitsche, Thierry Lobbedez, Ulrika Hahn Lundström and 7 more

Abstract read
In one paragraph

Article in Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Identifying Major Barriers to Home Dialysis (The IM-HOME Study): Findings From a National Survey of Patients, Care Partners, and Providers.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2024
    Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Home dialysis therapies.Clinical medicine (London, England) · 2023
    Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Edwina A BrownImperial College Renal and Transplant Centre, Imperial College Healthcare NHS Trust, London, UK.ORCID 0000-0002-4453-6486
Agneta EkstrandAbdomen Centre, Nephrology, Helsinki University Hospital, Helsinki, Finland.
Maurizio GallieniDepartment of Biomedical and Clinical Sciences, Università di Milano, Milan, Italy.
Maite Rivera GorrínServicio de Nefrología, Hospital Ramón y Cajal, Madrid, Spain.
Helga GudmundsdottirDepartment of Nephrology, Oslo University Hospital, Ulleval, Oslo, Norway.
Anabela Malho GuedesServiço de Nefrologia, Centro Hospitalar Universitário do Algarve, Faro, Portugal.ORCID 0000-0002-9627-908X
Marco HeidempergherNephrology and Dialysis Unit, ASST Fatebenefratelli Sacco, Milano, Italy.
Benno KitscheKuratorium für Dialyse und Nierentransplantation e.V., Cologne, Germany.
Thierry LobbedezNéphrologie, CHU CAEN, Normandy, France.ORCID 0000-0002-0945-8056
Ulrika Hahn LundströmDivision of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0003-1892-2225
Kate McCarthyBaxter Healthcare Ltd, Wallingford, Compton, Newbury, UK.
George J MellotteTrinity Health Kidney Centre, Tallaght University Hospital, Tallaght, Dublin, Ireland.ORCID 0000-0002-6477-1491
Olivier MoranneDepartment of Nephrology-Dialysis-Apheresis, CHU Caremeau Nimes, Nimes, France.ORCID 0000-0002-3127-1415
Dimitrios PetrasDepartment of Nephrology, General Hospital 'Hippokration', Athens, Greece.
Johan V PovlsenDepartment of Renal Medicine, Aarhus University Hospital, Aarhus, Denmark.
Sally PunzalanImperial College Renal and Transplant Centre, Imperial College Healthcare NHS Trust, London, UK.
Martin WiesholzerClinical Department for Internal Medicine, University Hospital St Poelten, Karl Landsteiner University of Health Sciences, St Poelten, Austria.

Funding

Department of Health
6 · The paper itself

Abstract

backgroundAvailability of assisted PD (asPD) increases access to dialysis at home, particularly for the increasing numbers of older and frail people with advanced kidney disease. Although asPD has been widely used in some European countries for many years, it remains unavailable or poorly utilized in others. A group of leading European nephrologists have therefore formed a group to drive increased availability of asPD in Europe and in their own countries.

methodsMembers of the group filled in a proforma with the following headings: personal experience, country experience, who are the assistants, funding of asPD, barriers to growth, what is needed to grow and their top three priorities.

resultsOnly 5 of the 13 countries surveyed provided publicly funded reimbursement for asPD. The use of asPD depends on overall attitudes to PD, with all respondents mentioning the need for nephrology team education and/or patient education and involvement in dialysis modality decision making. CONCLUSIONS AND CALL TO ACTION: Many people with advanced kidney disease would prefer to have their dialysis at home, yet if the frail patient chooses PD most healthcare systems cannot provide their choice. AsPD should be available in all countries in Europe and in all renal centres. The top priorities to make this happen are education of renal healthcare teams about the advantages of PD, education of and discussion with patients and their families as they approach the need for dialysis, and engagement with policymakers and healthcare providers to develop and support assistance for PD.

Indexed as

Kidney DiseasesKidney Failure, ChronicPeritoneal DialysisEuropeHumansRenal DialysisSpiperone4-aminospiroperidolSpiperonecommunity careequityfrailtyperitoneal dialysisquality of life

Identifiers

PMID35671088
PMCPMC9585462

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.